U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C20H23NO2.ClH
Molecular Weight 345.863
Optical Activity UNSPECIFIED
Defined Stereocenters 2 / 2
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of DEXOXADROL HYDROCHLORIDE

SMILES

Cl.[H][C@@]1(COC(O1)(C2=CC=CC=C2)C3=CC=CC=C3)[C@]4([H])CCCCN4

InChI

InChIKey=GYPWNVSWCIMIHQ-GRTNUQQKSA-N
InChI=1S/C20H23NO2.ClH/c1-3-9-16(10-4-1)20(17-11-5-2-6-12-17)22-15-19(23-20)18-13-7-8-14-21-18;/h1-6,9-12,18-19,21H,7-8,13-15H2;1H/t18-,19+;/m0./s1

HIDE SMILES / InChI

Molecular Formula C20H23NO2
Molecular Weight 309.4021
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 2 / 2
E/Z Centers 0
Optical Activity UNSPECIFIED

Molecular Formula ClH
Molecular Weight 36.461
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Dexoxadrol is a sigma receptor agonist. Dexoxadrol, the D-isomer of dioxodrol, which produces PCP-like behavioural effects and displaces bound [3H]PCP, was a potent blocker of the PCP-sensitive, voltage-gated K+ channel. Dexoxadrol was developed as analgesics for use in humans, however, severe side effects including psychotomimetic effects, unpleasant dreams and aberrations stopped the clinical evaluation of dexoxadrol. Dexoxadrol is a NMDA receptor antagonist, which possesses high affinity to the phencyclidine binding site within the NMDA receptor associated ion channel.

Approval Year

Targets

Targets

Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
Unknown

Approved Use

Unknown
Primary
Unknown

Approved Use

Unknown
Doses

Doses

DosePopulationAdverse events​
20 mg single, oral (unknown)
Studied dose
Dose: 20 mg
Route: oral
Route: single
Dose: 20 mg
Sources:
healthy, ADULT
n = 74
Health Status: healthy
Age Group: ADULT
Sex: F
Food Status: UNKNOWN
Population Size: 74
Sources:
Other AEs: psychosis...
Other AEs:
psychosis (5 patients)
Sources:
AEs

AEs

AESignificanceDosePopulation
psychosis 5 patients
20 mg single, oral (unknown)
Studied dose
Dose: 20 mg
Route: oral
Route: single
Dose: 20 mg
Sources:
healthy, ADULT
n = 74
Health Status: healthy
Age Group: ADULT
Sex: F
Food Status: UNKNOWN
Population Size: 74
Sources:
PubMed

PubMed

TitleDatePubMed
Molecular modeling of noncompetitive antagonists of the NMDA receptor: proposal of a pharmacophore and a description of the interaction mode.
2002 Feb
Structure-affinity relationship studies of non-competitive NMDA receptor antagonists derived from dexoxadrol and etoxadrol.
2005 Dec 15
Patents

Sample Use Guides

In hospitalized cancer and arthritic patients dexoxadrol at 10 mg or 20 mg dosage in combination with 600 mg of acetylsalicylic acid has analgesic properties significantly superior to either acetylsalicylic acid (600 mg) or codeine (60 mg) alone. Administration of dexoxadrol (20 mg, orally, twice daily) to 128 patients with severe pain gave complete relief to 50 % and partial relief to 28 % of the patients.
Route of Administration: Oral
In Vitro Use Guide
Dexoxadrol (10 uM) selectively blocked the secondary components of the synaptic response in rat hippocampal slices.
Substance Class Chemical
Created
by admin
on Fri Dec 15 15:25:50 GMT 2023
Edited
by admin
on Fri Dec 15 15:25:50 GMT 2023
Record UNII
T0C1IR71L8
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
DEXOXADROL HYDROCHLORIDE
USAN  
USAN  
Official Name English
D-DIOXADROL HYDROCHLORIDE
Common Name English
CL-911C
Code English
U-22559A
Code English
DIOXADROL HYDROCHLORIDE, (+)-
Common Name English
DEXOXADROL HYDROCHLORIDE [USAN]
Common Name English
U-22,559A
Code English
DEXOXADROL HCL
Common Name English
NIH-10375
Code English
PIPERIDINE, 2-((4S)-2,2-DIPHENYL-1,3-DIOXOLAN-4-YL)-, HYDROCHLORIDE, (2S)-
Systematic Name English
RELANE
Brand Name English
(+)-2-(2,2-DIPHENYL-1,3-DIOXOLAN-4-YL)PIPERIDINE HYDROCHLORIDE
Systematic Name English
DIOXADROL D-FORM HYDROCHLORIDE [MI]
Common Name English
Classification Tree Code System Code
NCI_THESAURUS C245
Created by admin on Fri Dec 15 15:25:50 GMT 2023 , Edited by admin on Fri Dec 15 15:25:50 GMT 2023
Code System Code Type Description
CAS
631-06-1
Created by admin on Fri Dec 15 15:25:50 GMT 2023 , Edited by admin on Fri Dec 15 15:25:50 GMT 2023
PRIMARY
ChEMBL
CHEMBL72982
Created by admin on Fri Dec 15 15:25:50 GMT 2023 , Edited by admin on Fri Dec 15 15:25:50 GMT 2023
PRIMARY
CAS
1162-15-8
Created by admin on Fri Dec 15 15:25:50 GMT 2023 , Edited by admin on Fri Dec 15 15:25:50 GMT 2023
SUPERSEDED
MESH
C005840
Created by admin on Fri Dec 15 15:25:50 GMT 2023 , Edited by admin on Fri Dec 15 15:25:50 GMT 2023
PRIMARY
FDA UNII
T0C1IR71L8
Created by admin on Fri Dec 15 15:25:50 GMT 2023 , Edited by admin on Fri Dec 15 15:25:50 GMT 2023
PRIMARY
NCI_THESAURUS
C77324
Created by admin on Fri Dec 15 15:25:50 GMT 2023 , Edited by admin on Fri Dec 15 15:25:50 GMT 2023
PRIMARY
PUBCHEM
71658
Created by admin on Fri Dec 15 15:25:50 GMT 2023 , Edited by admin on Fri Dec 15 15:25:50 GMT 2023
PRIMARY
MERCK INDEX
m4597
Created by admin on Fri Dec 15 15:25:50 GMT 2023 , Edited by admin on Fri Dec 15 15:25:50 GMT 2023
PRIMARY Merck Index
Related Record Type Details
PARENT -> SALT/SOLVATE
Related Record Type Details
ACTIVE MOIETY